Clinical Commentaries

Experts Discuss DACOTA Phase 3 Trial of Decitabine versus Hydroxyurea for Advanced Proliferative CMML
Mikkael A. Sekeres, MD, MS, Guillermo Garcia-Manero, MD, Rami S. Komrokji, MD
Clinical Commentaries published on May 4, 2021
In this activity, experts review the DACOTA phase 3 trial and provide their comments on the controversial study.
Read More

Results 1 - 1 of 1

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMPN.com | ManagingLymphoma.com | PracticalOncologist.com | PracticalHematologist.com | ManagingCVD.com | ManagingSCD.com | MediComWorldwide.com